SAFETY AND EFFICACY OF SOTATERCEPT IN TREATING PULMONARY ARTERIAL HYPERTENSION: A SYSTEMATIC REVIEW

被引：0
|
作者：
Khan, Farva Zaib
Sajid, Ahmed
Khan, Amina
Shahzad, Faizan
Azam, Saad
Asif, Hamza
Khan, Aoun Zaib
Khan, Zainab Zaib
Butt, Armeen
Ashraf, Danish Ali
Ahmed, Usman
Riaz, Khadeeja
机构：
来源：
CHEST | 2024年 / 166卷 / 04期
关键词：
D O I：
10.1016/j.chest.2024.06.3454
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：5827A / 5828A
页数：2
相关论文
共 50 条
  • [31] EFFICACY AND SAFETY OF SILDENAFIL ABOVE 60 MG DAILY IN PULMONARY ARTERIAL HYPERTENSION TREATMENT - A SYSTEMATIC LITERATURE REVIEW
    Cukier, F. N.
    Fernandes, R. A.
    Takemoto, M. L. S.
    Takemoto, M. M. S.
    Fujii, R. K.
    Mould, J. F.
    VALUE IN HEALTH, 2011, 14 (07) : A488 - A488
  • [32] Sotatercept for pulmonary arterial hypertension: something old and something new
    Rubin, Lewis J.
    Naeije, Robert
    EUROPEAN RESPIRATORY JOURNAL, 2023, 61 (01)
  • [33] Sotatercept in pulmonary arterial hypertension: something different or more of the same?
    Mark Toshner
    Nature Cardiovascular Research, 2023, 2 : 487 - 488
  • [34] HIV and pulmonary arterial hypertension: a systematic review
    Janda, S.
    Quon, B. S.
    Swiston, J.
    HIV MEDICINE, 2010, 11 (10) : 620 - 634
  • [35] Safety and Efficacy of Ambrisentan in the Treatment of Pulmonary Arterial Hypertension
    Valerio, Christopher J.
    Kabunga, Peter
    Coghlan, John G.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 541 - 556
  • [36] Comparative Effectiveness of Sotatercept and Approved Add-On Pulmonary Arterial Hypertension Therapies A Systematic Review and Network Meta-Analysis
    Pitre, Tyler
    Desai, Kairavi
    Mah, Jasmine
    Zeraatkar, Dena
    Humbert, Marc
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2024, 21 (08) : 1194 - 1203
  • [37] Is sotatercept, which traps activins and growth differentiation factors, a new dawn in treating pulmonary arterial hypertension (PAH)?
    Doggrell, Sheila A.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (07) : 589 - 593
  • [38] Sotatercept in pulmonary arterial hypertension: something different or more of the same?
    Toshner, Mark
    NATURE CARDIOVASCULAR RESEARCH, 2023, 2 (06): : 487 - 488
  • [39] Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death
    Humbert, Marc
    McLaughlin, Vallerie V.
    Badesch, David B.
    Ghofrani, H. Ardeschir
    Gibbs, J. Simon R.
    Gomberg-Maitland, Mardi
    Preston, Ioana R.
    Souza, Rogerio
    Waxman, Aaron B.
    Moles, Victor M.
    Savale, Laurent
    Vizza, Carmine Dario
    Rosenkranz, Stephan
    Shi, Yaru
    Miller, Barry
    Mackenzie, Harald S.
    Kim, Samuel S.
    Loureiro, Maria Jose
    Patel, Mahesh J.
    Koglin, Joerg
    Cornell, Alexandra G.
    Hoeper, Marius M.
    ZENITH Trial Investigators
    NEW ENGLAND JOURNAL OF MEDICINE, 2025,
  • [40] The safety and efficacy of treprostinil for the treatment of pulmonary arterial hypertension: a systematic review and meta-analysis of randomized controlled trials
    Khasawneh, H.
    Alqudah, M.
    Zaitoun, K.
    Al-Malkawi, F.
    Aldalal'ah, M.
    Alzghoul, B.
    EUROPEAN HEART JOURNAL, 2024, 45
12345